Seattle native works to support lifesaving research — like the immunotherapy that put his cancer in remission
May 3, 2018
| By Sabrina Richards / Fred Hutch News Service
Throughout the 2018 Major League Baseball season, Fred Hutch and the Seattle Mariners are recognizing “Hutch Heroes,” including lymphoma survivor Colin Craig, who works to support our lifesaving research.
Computer-generated algorithms could guide prevention, treatment of transplant complication, researchers showed
April 17, 2018
| By Susan Keown / Fred Hutch News Service
In its April issue, the American Journal of Epidemiology recognized a paper by Fred Hutchinson Cancer Research Center faculty member Dr. Elizabeth Krakow as one of its 10 best articles published in 2017.
T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers
April 16, 2018
| By Rachel Tompa / Fred Hutch News Service
In an effort to improve the efficacy of immunotherapy for solid tumors, Fred Hutch researchers have engineered a new type of protein that can rewire a 'kill switch' to stimulate T cells' activity instead.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.